ArticleBlood cancer journal2019

Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma.

Jeffrey Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.